Thank you for registering for Parks Associates. We have sent a verification email to your email address along with your temporary password. Please verify your email address via the link in this email as soon as possible. The link expires in 60 minutes.
January 11, 2017
William Blair upgraded Netflix, Inc. (NASDAQ:NFLX) to Outperform in August 2016 and believes there continues to be upside potential for the streaming video leader. Through William Blair's research, it believes that Netflix has a meaningful leg up on original programming within the over-the-top (OTT) streaming environment and suggest that these advantages might be underappreciated by investors. Moreover, contrary to some, William Blair believes OTT streaming still has plenty of room to grow both domestically and internationally, and Netflix is well positioned to benefit from this secular growth. Parks Associates estimates that more than 60% of broadband households in the United States subscribe to at least one subscription-video-on-demand (SVOD) service. William Blair believes the long-term penetration opportunity is 90% in the United States, in line with pay TV today.
From the article "Netflix, Inc. (NFLX): William Blair's Bull Case Points To $185 Price Target" by www.smartstocknews.com
Parks reported that 19 percent of U.S. broadband households intend to purchase a flat-panel TV set by the end of 2015. Roughly 40 percent of those households are looking for a 4K TV set, which is appr...
Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...
A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...
Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...
© 2023-2025 Parks Associates. All Rights Reserved. Privacy Policy
Design & Developed By Agency Partner Interactive
We use cookies in this website to give you the best experience on our site and show you relevant ads. To find out more, read our privacy policy and cookie policy .